Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Chi-Joan How MD

Chi-Joan How MD

Instructor of Medicine, Hematology Division, Harvard Medical School & Brigham and Women’s Hospital, Boston, Massachusetts

Chi-Joan How, MD, is currently an Associate Physician of Hematology at Brigham and Women’s Hospital and Instructor in Medicine at Harvard Medical School. She did her fellowship in hematology/oncology at Dana Farber Cancer Institute. She has clinical and research interest in myeloproliferative neoplasms, particularly relevant issues that face essential thrombocythemia and polycythemia vera patients including thrombosis/bleeding, symptom control, pregnancy complications, and COVID-19 outcomes.

Disclosures

Dr, How has no relevant disclosures.

Recent Contributions to PracticeUpdate:

  1. Predictors of Anemia Response to Momelotinib Therapy in Myelofibrosis and Impact on Survival
  2. Arterial Thrombosis Risk in Patients With COVID-19 With Myeloproliferative Neoplasms

Recently Updated